JPH10504455A - ボレリア・ブルグドルフェリのＯｓｐＧを含有するワクチン - Google Patents

ボレリア・ブルグドルフェリのＯｓｐＧを含有するワクチン

Info

Publication number
JPH10504455A
JPH10504455A JP8507024A JP50702496A JPH10504455A JP H10504455 A JPH10504455 A JP H10504455A JP 8507024 A JP8507024 A JP 8507024A JP 50702496 A JP50702496 A JP 50702496A JP H10504455 A JPH10504455 A JP H10504455A
Authority
JP
Japan
Prior art keywords
ospg
burgdorferi
protein
purified
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8507024A
Other languages
English (en)
Japanese (ja)
Inventor
ヴァリッヒ，ラインハルト
ズィーモン，マルクス・エム
クラマー，ミヒャエル・デー
Original Assignee
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・アインゲトラーゲナー・フェアアイン
ドイッチェス・クレプスフォルシュングスツェントルム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9416667A external-priority patent/GB9416667D0/en
Priority claimed from GBGB9503867.5A external-priority patent/GB9503867D0/en
Application filed by マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・アインゲトラーゲナー・フェアアイン, ドイッチェス・クレプスフォルシュングスツェントルム filed Critical マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・アインゲトラーゲナー・フェアアイン
Publication of JPH10504455A publication Critical patent/JPH10504455A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
JP8507024A 1994-08-17 1995-08-11 ボレリア・ブルグドルフェリのＯｓｐＧを含有するワクチン Pending JPH10504455A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9416667A GB9416667D0 (en) 1994-08-17 1994-08-17 Vaccines and diagnostics
GB9416667.5 1994-08-17
GB9503867.5 1995-02-25
GBGB9503867.5A GB9503867D0 (en) 1995-02-25 1995-02-25 Vaccines and diagnostics
PCT/EP1995/003213 WO1996005313A1 (en) 1994-08-17 1995-08-11 VACCINES CONTAINING BORRELIA BURGDORFERI OspG

Publications (1)

Publication Number Publication Date
JPH10504455A true JPH10504455A (ja) 1998-05-06

Family

ID=26305468

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8507024A Pending JPH10504455A (ja) 1994-08-17 1995-08-11 ボレリア・ブルグドルフェリのＯｓｐＧを含有するワクチン

Country Status (12)

Country Link
EP (1) EP0781338A1 (cs)
JP (1) JPH10504455A (cs)
KR (1) KR970705636A (cs)
CN (1) CN1159831A (cs)
AU (1) AU687620B2 (cs)
BR (1) BR9508802A (cs)
CA (1) CA2197712A1 (cs)
CZ (1) CZ42497A3 (cs)
HU (1) HUT77251A (cs)
NZ (1) NZ291818A (cs)
PL (1) PL318672A1 (cs)
WO (1) WO1996005313A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19632862B4 (de) 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
CN103229055A (zh) * 2010-09-27 2013-07-31 康奈尔大学 莱姆病的诊断方法
CN111196842A (zh) * 2020-01-09 2020-05-26 济南大学 一种外膜转运通道蛋白的非跨膜结构域的表达纯化方法

Also Published As

Publication number Publication date
WO1996005313A1 (en) 1996-02-22
CN1159831A (zh) 1997-09-17
NZ291818A (en) 1998-09-24
AU687620B2 (en) 1998-02-26
HUT77251A (hu) 1998-03-02
CZ42497A3 (en) 1997-10-15
EP0781338A1 (en) 1997-07-02
AU3345495A (en) 1996-03-07
KR970705636A (ko) 1997-10-09
CA2197712A1 (en) 1996-02-22
PL318672A1 (en) 1997-07-07
BR9508802A (pt) 1997-12-30

Similar Documents

Publication Publication Date Title
Wallich et al. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo
US5747294A (en) Compositions and methods for the prevention and diagnosis of lyme disease
US6221363B1 (en) Vaccine for the prevention of lyme disease
US7605248B2 (en) Recombinant constructs of Borrelia burgdorferi
CA2224015A1 (en) Streptococcal heat shock proteins members of the hsp70 family
US5656451A (en) OspE, OspF, and S1 polypeptides in borrelia burgdorferi
JP4358909B2 (ja) 歯周炎の診断および治療用のポルフィロモナス・ジンジバリス抗原
JPH08509371A (ja) ライム病の予防及び治療のためのＯｓｐＣ抗原ワクチンの免疫原性製剤及びかかる抗原の調製のための組換え方法
HUT64596A (en) Recombinant vaccine against swine pleuropneumonie
US6676942B1 (en) Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
JPH10504455A (ja) ボレリア・ブルグドルフェリのＯｓｐＧを含有するワクチン
WO1994020536A1 (en) Methods, compositions, and kits for diagnosing lyme disease
US6716591B1 (en) B. burgdorferi polypeptides
EP1535928B1 (en) Vaccine compositions comprising Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis
MXPA97001224A (en) Vaccines against borrelia burgdorferi o
HK1003060A (en) Vaccines containing borrelia burgdorferi ospg
WO1995009919A1 (en) Vaccines and diagnostics for borrelia burgdorferi
AU713844B2 (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
CA2253834A1 (en) B. burgdorferi polypeptides expressed in vivo
KR19990022600A (ko) 진단및치료용의헬리코박터피롤리관련핵산및아미노산서열